HRNYSEReal Estate Investment TrustsFiscal year ends December 31

Healthcare Realty Trust Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$17.24−0.24 (-1.37%)

Close on Oct 19, 2026

Market cap: $5.90B
P/E (TTM): –
Dividend yield: 6.38%

Healthcare Realty Trust Inc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	1,181	1,268	1,344	933	535	500	692	696	614	461	404	372	322	300	272	203	129
General & Administrative	73	83	58	53	34	31	41	35	33	29	26	25	24	22	21	16	12
Total Costs & Expenses	–	–	–	–	707	669	642	647	576	359	310	288	255	269	226	182	131
Operating Income	–	–	–	–	–	–	–	–	124	102	94	83	66	30	46	22	-1.20
Interest Expense	209	242	259	147	53	56	97	102	85	60	55	52	47	40	39	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	0.09	0.17	0.12	0.25
Income from Equity Investments	-0.19	-0.14	-1.68	-0.69	-0.80	-0.46	1.88	1.74	0.78	0	0	–	–	–	–	–	–
Other Non-Operating Income	-342	-697	-336	65	-15	-7.22	0.84	0.43	0.03	0.29	-1.43	0.05	0.04	0.09	0.17	–	–
Asset Impairment Charges	0	251	0	0	–	–	–	–	14	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	243	-2.11	0	0	–	–	–	–	–	–	–	–	–	–
Income from Continuing Operations	–	–	–	38	65	70	–	–	–	–	–	–	23	-25	5.12	–	–
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	1.11	0.57	0.42	–	–
Net Income incl. Noncontrolling Interests	-249	-664	-282	41	67	72	31	218	66	47	34	46	25	-24	5.59	-7.92	-25
Minority Interest in Earnings	-3.41	-9.42	-3.82	-0.20	0	0	0.60	4.16	1.66	1.43	0.63	0.62	0.42	0.06	0.05	–	–
Net Income	-246	-654	-278	41	67	72	30	213	64	46	33	45	24	-24	5.54	-7.90	-25
EPS (Basic)(per share)	-0.71	-1.81	-0.74	0.15	0.45	0.52	0.15	1.04	0.35	0.34	0.26	0.38	0.21	-0.22	0.04	-0.10	-0.44
EPS (Diluted)(per share)	-0.71	-1.81	-0.74	0.15	0.45	0.52	0.14	1.02	0.34	0.33	0.26	0.37	0.21	-0.22	0.04	-0.10	-0.44
Shares Outstanding (Basic, Weighted)(shares)	350	366	379	252	143	134	206	206	181	137	126	120	114	111	112	83	56
Shares Outstanding (Diluted, Weighted)(shares)	350	366	379	254	143	134	210	210	185	140	128	121	115	111	112	83	56
Dividend per Share(per share)	1.10	1.24	1.24	1.24	1.21	1.20	1.25	1.23	1.21	1.19	1.17	1.16	1.15	1.28	1.45	1.46	–
EBITDA	–	–	–	–	–	–	–	–	369	279	248	224	188	147	153	100	52

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: -7.6%
Return on equity, FY2025: -5.0%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: 5.15
Price to book: 1.40
Dividend yield: 6.38%